Psychemedics Corporation Announces 2017 Q2 Earnings

  ACTON, Mass., Aug. 2, 2017,/PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD) today announced second-quarter financial results for the period ended June 30, 2017.  The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 14, 2017, to be paid on August 24, 2017.  This will be the … Read more

Psychemedics Corporation Responds To Recent Price Volatility

Acton, Massachusetts, January 31, 2017 — Psychemedics Corporation (NASDAQ:PMD) today announced that recent volatility in its stock price on January 31, 2017 appears to have been caused by a news report of a court ruling in Brazil involving Psychemedics Brasil. Psychemedics Brasil is an independent distributor of Psychemedics Corporation’s hair testing services in Brazil, and … Read more

Trucking Alliance Companies Petition USDOT to Close Drug Test Loophole

NEWS RELEASE October 27, 2016 Trucking Alliance Asks FMSCA To Allow Hair Drug Testing October 28th, 2016 Washington, D.C. Transportation companies affiliated with The Alliance for Driver Safety & Security (aka Trucking Alliance) have petitioned the Federal Motor Carrier Safety Administration (FMCSA) to allow hair testing in lieu of a urinalysis to comply with pre-employment … Read more

Psychemedics Corporation Earns Prestigious Recognition for Superior Customer Service

Award-Winning Customer Support Team is now a “Certified Center of Excellence” ACTON, Mass., Sept. 13, 2016 /PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD), the world’s leading and largest hair analysis drug testing company, announced that it has been certified as a Center of Excellence by BenchmarkPortal. The Center of Excellence recognition is one of the most prestigious … Read more

Psychemedics Corporation Announces Record Revenues And Earnings

DECLARES 80th CONSECUTIVE DIVIDEND — 20 YEARS OF QUARTERLY DIVIDENDS ACTON, Mass., July 26, 2016,/PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD) today announced second-quarter financial results for the period ended June 30, 2016.  The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 5, 2016, to be … Read more

Psychemedics Announces Addition Of FDA Cleared Drugs

World’s largest hair drug testing company & scientific leader launches new screening tests for Oxymorphone and D-Amphetamine/Adderall®. ACTON, Mass., June 2, 2015 /PRNewswire/ — Psychemedics Corporation PMD, -0.06% hair testing pioneer and global leader for over twenty-five years, announced the addition of 2 new drugs to the company’s drug testing panels. In response to growing … Read more